Skip to main navigation Skip to search Skip to main content

Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy

  • Drew Moghanaki
  • , Bridget F. Koontz
  • , Jeremy D. Karlin
  • , Wen Wan
  • , Nitai Mukhopadhay
  • , Michael P. Hagan
  • , Mitchell S. Anscher

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Success rates with salvage radiotherapy (SRT) in men who have a postprostatectomy biochemical relapse are suboptimal. One treatment- intensification strategy includes elective irradiation of the pelvic lymph nodes with whole pelvis radiotherapy (WPRT). Methods: An inter-institutional retrospective cohort study compared outcomes for patients who received SRT at 2 separate academic institutions with disparate treatment paradigms: almost exclusively favoring WPRT (n = 112) versus limiting treatment to the prostate bed (PBRT) (n = 135). Patients were excluded if they had lymph node involvement or if they received androgen-deprivation therapy. The Cox proportional hazards model was used to adjust for potential confounders. Results: In total, 247 patients were analyzed with a median follow-up of 4 years. The pre-SRT prostate-specific antigen (PSA) level (adjusted hazard ratio [HR], 1.58; P <.0001) and a Gleason score of 8 to 10 (adjusted HR, 3.21; P <.0001) were identified as independent predictors of increased risk of biochemical PSA progression after SRT. However, WPRT was not independently associated with biochemical progression-free survival in the multivariate model (adjusted HR, 0.79; P =.20). Neither low-risk patients nor high-risk patients (defined a priori by a preoperative PSA level ≥20 ng/mL, a pathologic Gleason score between 8 and 10, or pathologic T3 tumor classification) benefited from WPRT. Overall survival was similar between treatment groups. When restricting the analysis to patients with pre-SRT PSA levels ≥0.4 ng/mL (n = 139), WPRT was independently associated with a 53% reduction in the risk of biochemical progression (adjusted HR, 0.47; P =.031). Conclusions: WPRT did not improve outcomes among the entire group but was independently associated with improved biochemical control among patients with pre-SRT PSA levels ≥0.4 ng/mL.

Original languageEnglish (US)
Pages (from-to)52-60
Number of pages9
JournalCancer
Volume119
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Keywords

  • biochemical relapse
  • elective lymph node
  • lymph nodes
  • pelvic lymph nodes
  • postprostatectomy
  • prostate cancer
  • prostatectomy
  • radiotherapy
  • salvage radiotherapy
  • whole pelvis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy'. Together they form a unique fingerprint.

Cite this